Details

Autor(en) / Beteiligte

• Jones, Stacie M
• Vickery, Brian P., MD, FAAAAI
• Bird, J. Andrew, MD, FAAAAI
• Spergel, Jonathan M., MD, PhD, FAAAAI
• Rachid, Rima A., MD, FAAAAI
• Assa'ad, Amal H., MD,, FAAAAI
• Wang, Julie, MD
• Leonard, Stephanie A., MD
• Laubach, Susan Stefanac, MD, FAAAAI
• Kim, Edwin, MD
• Davis, Benjamin P., MD, PhD
• Welch, Michael, MD, FAAAAI
• Heimall, Jennifer, MD
• Cianferoni, Antonella, MD, PhD, FAAAAI
• MacGinnitie, Andrew J., MD, PhD, FAAAAI
• Crestani, Elena, MD, MS
• Radwan, Amr, MBBChir, FFPM
• Vereda, Andrea, MD, PhD
• Adelman, Daniel C., MD, FAAAAI
• Burks, A. Wesley, MD

Titel

At-home Dosing Adherence During Characterized Oral Desensitization Immunotherapy (CODIT) for Peanut Allergy

Ist Teil von

• Journal of allergy and clinical immunology, 2017-02, Vol.139 (2), p.AB256-AB256

Ort / Verlag

St. Louis: Elsevier Inc

Erscheinungsjahr

2017

Quelle

Alma/SFX Local Collection

Beschreibungen/Notizen

• Rationale AR101, a pharmaceutical-grade peanut protein formulation, was well tolerated and demonstrated robust activity in a Phase 2, double-blind, placebo-controlled trial in 4-21 year olds.